Raena Morgan: On the website for SoyLife it talks about the prebiotic effect. What, exactly, is a prebiotic? Dr. Marian Verbruggen: Prebiotic effects means that in the product you have a component that can stimulate the good micro flora that you already have in your system. Raena Morgan: Oh really? Dr. Marian Verbruggen: Yes, usually it’s linked to [the] fiber portion of your product. In the case of SoyLife we’re strictly talking about the SoyLife complex and to a lesser extent… the extracts. We’re referring to the oligosaccharides present in the product. That can have a prebiotic effect. So, it stimulates the good micro flora in your intestines. We’ve proven that it stimulates the lactic acid material in the gut and furthermore, we also proved that the stimulation of the gut micro flora actually helps you metabolize the isoflavones. So, by this combination of the oligosaccharides together with the isoflavones in the SoyLife Complex product you can actually get a higher benefit of the isoflavones because you metabolize the isoflavones much better. So, you absorb more. Raena Morgan: Absorb more. Could you tell us a little bit about the Opus Study? Dr. Marian Verbruggen: The Opus Study has been a funded study; a few years ago it started. It’s a 4 and a half million dollar funded study. It was started to do a long term study on bone health, a 2 year study. It was a multi-site study, 3 universities were involved with altogether 400 patients. Raena Morgan: That’s a lot. Dr. Marian Verbruggen: Yes, that’s really a lot. So, the Baylor College of Medicine in Houston was involved in the study. Also the University of California in Davis and the University of Georgia in Athens, Georgia were involved in the studies. All sides provided 130—135 volunteers that participated in the study. They took SoyLife for 2 years at a dose of 80 milligrams or 120 milligrams compared to the placebo and it was tested for the bone health conditions— bone parameters, but also for safety parameters. And so, those women [were] really checked very intensely to make sure there was nothing—any safety issue, any adverse effect related to a long term soy intake at a reasonably high dose. Raena Morgan: And, there were none? Dr. Marian Verbruggen: There were no adverse effects related to the SoyLife intake. And, the results that we have so far is that the bone, the total body bone mineral density stays where it is, so no reduction there, good benefits for the postmenopausal women. Raena Morgan: That sounds like a very valuable study. Dr. Marian Verbruggen: That looks really like a very valuable study and we are really hoping that the researchers will start writing up the study as soon as possible. Raena Morgan: Good. Thank you, Dr. Verbruggen.